Chung‐Ze Wu

994 total citations
78 papers, 688 citations indexed

About

Chung‐Ze Wu is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Chung‐Ze Wu has authored 78 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Endocrinology, Diabetes and Metabolism, 32 papers in Epidemiology and 18 papers in Molecular Biology. Recurrent topics in Chung‐Ze Wu's work include Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers), Adipokines, Inflammation, and Metabolic Diseases (20 papers) and Diabetes Management and Research (15 papers). Chung‐Ze Wu is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers), Adipokines, Inflammation, and Metabolic Diseases (20 papers) and Diabetes Management and Research (15 papers). Chung‐Ze Wu collaborates with scholars based in Taiwan, United States and Italy. Chung‐Ze Wu's co-authors include Dee Pei, Jiunn‐Diann Lin, Chang‐Hsun Hsieh, Chun‐Hsien Hsu, Yi-Jen Hung, Dee Pei, Fone‐Ching Hsiao, Jin-Shuen Chen, Yen‐Lin Chen and Yuh‐Feng Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Chung‐Ze Wu

77 papers receiving 673 citations

Peers

Chung‐Ze Wu
Yang Ho Kang South Korea
Yiting Xu China
Jiunn‐Diann Lin Taiwan
Weijun Gu China
Adrian Vlad Romania
Silvia Briganti Italy
Maria Paola Buzzi Italy
Luca D’Onofrio Italy
Surasak Kantachuvesiri Thailand
Wenjuan Zhao China
Yang Ho Kang South Korea
Chung‐Ze Wu
Citations per year, relative to Chung‐Ze Wu Chung‐Ze Wu (= 1×) peers Yang Ho Kang

Countries citing papers authored by Chung‐Ze Wu

Since Specialization
Citations

This map shows the geographic impact of Chung‐Ze Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Ze Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Ze Wu more than expected).

Fields of papers citing papers by Chung‐Ze Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Ze Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Ze Wu. The network helps show where Chung‐Ze Wu may publish in the future.

Co-authorship network of co-authors of Chung‐Ze Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Ze Wu. A scholar is included among the top collaborators of Chung‐Ze Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Ze Wu. Chung‐Ze Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chung‐Ze, et al.. (2023). Using Machine Learning to Predict Abnormal Carotid Intima-Media Thickness in Type 2 Diabetes. Diagnostics. 13(11). 1834–1834. 9 indexed citations
2.
3.
Wu, Chung‐Ze, et al.. (2023). Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs. Pharmaceuticals. 16(10). 1435–1435. 3 indexed citations
4.
Lu, Jin‐Ying, Horng‐Yih Ou, Chung‐Ze Wu, et al.. (2023). A randomized trial on the effect of transcutaneous electrical nerve stimulator on glycemic control in patients with type 2 diabetes. Scientific Reports. 13(1). 2662–2662. 2 indexed citations
5.
Huang, Li-Ying, Fang-Yu Chen, Chun‐Heng Kuo, et al.. (2022). Comparing Multiple Linear Regression and Machine Learning in Predicting Diabetic Urine Albumin–Creatinine Ratio in a 4-Year Follow-Up Study. Journal of Clinical Medicine. 11(13). 3661–3661. 11 indexed citations
6.
Chang, Anne B., et al.. (2022). Prevalence and risk factors for latent tuberculosis among diabetes patients in Taiwan: A cross-sectional study. The Journal of Infection in Developing Countries. 16(4). 644–649. 5 indexed citations
7.
Wu, Chung‐Ze, Chieh‐Hua Lu, Jiunn‐Diann Lin, et al.. (2020). Relationships between white blood cell count and insulin resistance, glucose effectiveness, and first- and second-phase insulin secretion in young adults. Medicine. 99(43). e22215–e22215. 7 indexed citations
8.
Pei, Dee, et al.. (2020). Predictors of abnormality in thallium myocardial perfusion scans for type 2 diabetes. Heart and Vessels. 36(2). 180–188. 4 indexed citations
9.
Lin, Chien‐Ming, Chang‐Hsun Hsieh, Chien‐Hsing Lee, et al.. (2017). Predictive Value of Serum Gamma-glutamyltranspeptidase for Future Cardiometabolic Dysregulation in Adolescents- a 10-year longitudinal study. Scientific Reports. 7(1). 9636–9636. 3 indexed citations
10.
Hsu, Chun‐Hsien, Chang‐Hsun Hsieh, Chung‐Ze Wu, et al.. (2017). High normotension is associated with future metabolic syndrome but not cardiovascular disease. Medicine. 96(25). e7227–e7227. 1 indexed citations
11.
12.
Chen, Jin-Shuen, Chung‐Ze Wu, Tzu-Ling Tseng, et al.. (2016). Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models. Journal of Biomedical Science. 23(1). 24–24. 16 indexed citations
13.
Lin, Jiunn‐Diann, et al.. (2016). Identification of Normal Blood Pressure in Different Age Group. Medicine. 95(14). e3188–e3188. 18 indexed citations
14.
Hsiao, Po-Jen, Yuh‐Feng Lin, Chung‐Ze Wu, et al.. (2016). Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan. Clinical and Experimental Nephrology. 21(4). 694–704. 8 indexed citations
15.
Lin, Jiunn‐Diann, et al.. (2016). Comparison of Second-Phase Insulin Secretion Derived from Standard and Modified Low-Dose Graded Glucose Infusion Tests. Canadian Journal of Diabetes. 40(6). 529–534. 3 indexed citations
16.
Hsu, Chun‐Hsien, Jiunn‐Diann Lin, Chang‐Hsun Hsieh, et al.. (2014). Using hematogram model to predict future metabolic syndrome in elderly: a 4-year longitudinal study. The Aging Male. 18(1). 38–43. 9 indexed citations
17.
Hsieh, Chang‐Hsun, et al.. (2012). The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: A pilot study. Obesity Research & Clinical Practice. 7(3). e206–e210. 6 indexed citations
18.
Wu, Chung‐Ze, et al.. (2010). Comparison of insulin sensitivity, glucose sensitivity, and first phase insulin secretion in patients treated with repaglinide or gliclazide. Archives of Pharmacal Research. 33(3). 411–416. 5 indexed citations
19.
Lin, Jiunn‐Diann, et al.. (2009). The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus. Metabolism. 59(6). 780–786. 19 indexed citations
20.
Hsiao, Fone‐Ching, Chung‐Ze Wu, Sheng‐Chiang Su, et al.. (2009). Baseline forced expiratory volume in the first second as an independent predictor of development of the metabolic syndrome. Metabolism. 59(6). 848–853. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Ho Kang Breakdown of academic impact, for papers by Yiting Xu Breakdown of academic impact, for papers by Jiunn‐Diann Lin Breakdown of academic impact, for papers by Weijun Gu Breakdown of academic impact, for papers by Adrian Vlad Breakdown of academic impact, for papers by Silvia Briganti Breakdown of academic impact, for papers by Maria Paola Buzzi Breakdown of academic impact, for papers by Luca D’Onofrio Breakdown of academic impact, for papers by Surasak Kantachuvesiri Breakdown of academic impact, for papers by Wenjuan Zhao
Rankless by CCL
2026